The Future: the Galleri Trial

The Greater Manchester Cancer Podcast

In episode two, Steve Bland explores the exciting new Galleri Trial announced by NHS England and healthcare company GRAIL UK, which could see a single blood test used to spot the early signs of 50 cancers, including some of the most difficult to diagnose and detect.

The trial is being rolled out in eight parts of the country, and one of those is right here in Greater Manchester. Steve gets the lowdown on the science from Sara Hiom, the Director of Cancer Intelligence at GRAIL, finds out how it will work on the ground from Dr Matthias Hohmann, who is a GP in Oldham and the Clinical Director for Cancer at Oldham CCG, and gets the thoughts of patient Julie Colville.

For more information about GM Cancer click here.

And to find out about the Galleri Trial, visit NHS-Galleri Trial | Detecting cancer early.

Content Restricted

This episode cannot be played on the web in your country or region.

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada